BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22919238)

  • 1. Indomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: is it the magic bullet?
    Yang D; Draganov PV
    World J Gastroenterol; 2012 Aug; 18(31):4082-5. PubMed ID: 22919238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
    Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
    Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach?
    Tammaro S; Caruso R; Pallone F; Monteleone G
    World J Gastroenterol; 2012 Sep; 18(34):4635-8. PubMed ID: 23002332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?
    Cheon YK
    Korean J Intern Med; 2013 Mar; 28(2):141-8. PubMed ID: 23525264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement.
    Choksi NS; Fogel EL; Cote GA; Romagnuolo J; Elta GH; Scheiman JM; Chak A; Mosler P; Higgins PD; Korsnes SJ; Schmidt SE; Sherman S; Lehman GA; Elmunzer BJ;
    Gastrointest Endosc; 2015 Jan; 81(1):150-5. PubMed ID: 25527053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a cost-effectiveness analysis.
    Nicolás-Pérez D; Castilla-Rodríguez I; Gimeno-García AZ; Romero-García R; Núñez-Díaz V; Quintero E
    Pancreas; 2015 Mar; 44(2):204-10. PubMed ID: 25406954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
    Ahmad D; Lopez KT; Esmadi MA; Oroszi G; Matteson-Kome ML; Choudhary A; Bechtold ML
    Pancreas; 2014 Apr; 43(3):338-42. PubMed ID: 24622061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cost-Effectiveness Analysis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis in the United States.
    Thiruvengadam NR; Saumoy M; Schneider Y; Attala S; Triggs J; Lee P; Kochman ML
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):216-226.e42. PubMed ID: 34481952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
    Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
    Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
    Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial.
    Elmunzer BJ; Serrano J; Chak A; Edmundowicz SA; Papachristou GI; Scheiman JM; Singh VK; Varadarajulu S; Vargo JJ; Willingham FF; Baron TH; Coté GA; Romagnuolo J; Wood-Williams A; Depue EK; Spitzer RL; Spino C; Foster LD; Durkalski V;
    Trials; 2016 Mar; 17(1):120. PubMed ID: 26941086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.
    Fogel EL; Lehman GA; Tarnasky P; Cote GA; Schmidt SE; Waljee AK; Higgins PDR; Watkins JL; Sherman S; Kwon RSY; Elta GH; Easler JJ; Pleskow DK; Scheiman JM; El Hajj II; Guda NM; Gromski MA; McHenry L; Arol S; Korsnes S; Suarez AL; Spitzer R; Miller M; Hofbauer M; Elmunzer BJ;
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):132-141. PubMed ID: 31780277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
    Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail.
    Wagh MS; Sherman S
    Am J Gastroenterol; 2007 May; 102(5):984-6. PubMed ID: 17489783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
    Wan J; Ren Y; Zhu Z; Xia L; Lu N
    BMC Gastroenterol; 2017 Mar; 17(1):43. PubMed ID: 28298192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review.
    Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials.
    Shi N; Deng L; Altaf K; Huang W; Xue P; Xia Q
    Turk J Gastroenterol; 2015 May; 26(3):236-40. PubMed ID: 26006198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.